1.27 N/A 0.58% 0.00% Distribution costs (41.75 ) (24.14 ) (17.61 ) 72.95% (19.11%) (13.74%) Administrative expenses (95.74 ) (94.34 ) (1.40 ) 1.48% (43.82%) (53.71%) Other Expenses Impairment loss of
-27.5% -24.5% 2,120.4 1,782.4 -15.9% Other income 31.8 15.9 22.9 -28.1% +44.1% 51.7 38.7 -25.1% Selling and distribution expenses 587.2 536.7 463.7 -21.0% -13.6% 1,175.1 1,000.4 -14.9% Administrative
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
เท่าขึ้นไปที่รับผิดชอบงาน ด้านที่ปรึกษาทางการเงิน “IB team members” “บริษัทร่วม” “บริษัทย่อย” และ “ผู้ถือหุ้นรายใหญ่” พนักงานที่ปฏิบัติงานสายงานที่ปรึกษาทางการเงินของที่ปรึกษา ทางการเงิน ให้มีความหมาย
that on august 15, 2019 BOD meet approved the loan by 8.5% and 10 years repayment term which is above market price. And appoint management team go negotiate further. By the way, there is a risk which
giving away cash to the people and welfare payments to the unemployed. While employment remained weak, Policy clarity Direction of the business team and political climate It is a huge risk to the future
unexpected pandemic of COVID-19, resulted to unavoidable significant impact to revenue and operating result of the Company. However, the Executive and their team has brainstormed and made a strategic planning